@EddieLindley1 @rjmcm @k_jank @PeterAttiaMD "the vast majority of people infected do not have a post viral syndrome of any kind" False. https://t.co/bf5AZZe9X6
RT @PaulWhiteleyPhD: @MECFSNews The paper (abstract) is here: https://t.co/bVvKLJJiI5
RT @AngelmColque: 📌 Un estudio muestra que los sintomas #PostCovid19 pueden durar 52% a los 30 días y un 35 % a los 60 días. #LongCovid #C…
@um_midas affiliated faculty and @umichsph ’s Nancy Fleischer, Mike Elliott and team examine the long term effects of COVID-19. https://t.co/3LkayswtJS
RT @kenmomd: 関連して患者報告式の尺度の研究でとても参考になる文献 COSMIN - Improving the selection of outcome measurement instruments https://t.co/gcXbPoaqPF
RT @IDSAInfo: New in CID: In a population-based probability sample of 593 symptomatic COVID-19 cases, 52.5% had persistent symptoms 30 days…
RT @IDSAInfo: New in CID: In a population-based probability sample of 593 symptomatic COVID-19 cases, 52.5% had persistent symptoms 30 days…
RT @ahandvanish: Wow - new prevalence study looking specifically at symptomatic COVID patients finds 35% still symptomatic at 2 months. T…
RT @ahandvanish: Wow - new prevalence study looking specifically at symptomatic COVID patients finds 35% still symptomatic at 2 months. T…
RT @ahandvanish: Wow - new prevalence study looking specifically at symptomatic COVID patients finds 35% still symptomatic at 2 months. T…
RT @ahandvanish: Wow - new prevalence study looking specifically at symptomatic COVID patients finds 35% still symptomatic at 2 months. T…
RT @IDSAInfo: New in CID: In a population-based probability sample of 593 symptomatic COVID-19 cases, 52.5% had persistent symptoms 30 days…
RT @Guia_ABE: Destacado de hoy: Population-based estimates of post-acute sequelae of SARS-CoV-2 infection (PASC) prevalence and characteri…
RT @kenmomd: COVID-19発症後30日以上、60日以上の持続的な症状と定義した後遺症の有病率 n=593 Population-based estimates of post-acute sequelae of SARS-CoV-2 infection (PAS…
RT @IDSAInfo: New in CID: In a population-based probability sample of 593 symptomatic COVID-19 cases, 52.5% had persistent symptoms 30 days…
RT @IDSAInfo: New in CID: In a population-based probability sample of 593 symptomatic COVID-19 cases, 52.5% had persistent symptoms 30 days…
RT @IDSAInfo: New in CID: In a population-based probability sample of 593 symptomatic COVID-19 cases, 52.5% had persistent symptoms 30 days…
RT @ahandvanish: Wow - new prevalence study looking specifically at symptomatic COVID patients finds 35% still symptomatic at 2 months. T…
RT @IDSAInfo: New in CID: In a population-based probability sample of 593 symptomatic COVID-19 cases, 52.5% had persistent symptoms 30 days…
RT @IDSAInfo: New in CID: In a population-based probability sample of 593 symptomatic COVID-19 cases, 52.5% had persistent symptoms 30 days…
RT @ahandvanish: Wow - new prevalence study looking specifically at symptomatic COVID patients finds 35% still symptomatic at 2 months. T…
😮😮😮😮
RT @ahandvanish: Wow - new prevalence study looking specifically at symptomatic COVID patients finds 35% still symptomatic at 2 months. T…
RT @ahandvanish: Wow - new prevalence study looking specifically at symptomatic COVID patients finds 35% still symptomatic at 2 months. T…
RT @ahandvanish: Wow - new prevalence study looking specifically at symptomatic COVID patients finds 35% still symptomatic at 2 months. T…
RT @ahandvanish: Wow - new prevalence study looking specifically at symptomatic COVID patients finds 35% still symptomatic at 2 months. T…
RT @ItsAngInLA: So estimates of 1/3 of COVID patients will get #LongCovid seem to be right on target… https://t.co/21QWyyxhDK
RT @ahandvanish: Wow - new prevalence study looking specifically at symptomatic COVID patients finds 35% still symptomatic at 2 months. T…
RT @kenmomd: COVID-19発症後30日以上、60日以上の持続的な症状と定義した後遺症の有病率 n=593 Population-based estimates of post-acute sequelae of SARS-CoV-2 infection (PAS…
RT @ahandvanish: Wow - new prevalence study looking specifically at symptomatic COVID patients finds 35% still symptomatic at 2 months. T…
RT @kenmomd: 関連して患者報告式の尺度の研究でとても参考になる文献 COSMIN - Improving the selection of outcome measurement instruments https://t.co/gcXbPoaqPF
RT @ahandvanish: Wow - new prevalence study looking specifically at symptomatic COVID patients finds 35% still symptomatic at 2 months. T…
RT @kenmomd: COVID-19発症後30日以上、60日以上の持続的な症状と定義した後遺症の有病率 n=593 Population-based estimates of post-acute sequelae of SARS-CoV-2 infection (PAS…
RT @kenmomd: COVID-19発症後30日以上、60日以上の持続的な症状と定義した後遺症の有病率 n=593 Population-based estimates of post-acute sequelae of SARS-CoV-2 infection (PAS…
RT @ahandvanish: Wow - new prevalence study looking specifically at symptomatic COVID patients finds 35% still symptomatic at 2 months. T…
RT @kenmomd: COVID-19発症後30日以上、60日以上の持続的な症状と定義した後遺症の有病率 n=593 Population-based estimates of post-acute sequelae of SARS-CoV-2 infection (PAS…
RT @IDSAInfo: New in CID: In a population-based probability sample of 593 symptomatic COVID-19 cases, 52.5% had persistent symptoms 30 days…
RT @IDSAInfo: New in CID: In a population-based probability sample of 593 symptomatic COVID-19 cases, 52.5% had persistent symptoms 30 days…
RT @kenmomd: COVID-19発症後30日以上、60日以上の持続的な症状と定義した後遺症の有病率 n=593 Population-based estimates of post-acute sequelae of SARS-CoV-2 infection (PAS…
RT @kenmomd: COVID-19発症後30日以上、60日以上の持続的な症状と定義した後遺症の有病率 n=593 Population-based estimates of post-acute sequelae of SARS-CoV-2 infection (PAS…
関連して患者報告式の尺度の研究でとても参考になる文献 COSMIN - Improving the selection of outcome measurement instruments https://t.co/gcXbPoaqPF
RT @IDSAInfo: New in CID: In a population-based probability sample of 593 symptomatic COVID-19 cases, 52.5% had persistent symptoms 30 days…
RT @kenmomd: COVID-19発症後30日以上、60日以上の持続的な症状と定義した後遺症の有病率 n=593 Population-based estimates of post-acute sequelae of SARS-CoV-2 infection (PAS…
RT @kenmomd: COVID-19発症後30日以上、60日以上の持続的な症状と定義した後遺症の有病率 n=593 Population-based estimates of post-acute sequelae of SARS-CoV-2 infection (PAS…
RT @kenmomd: COVID-19発症後30日以上、60日以上の持続的な症状と定義した後遺症の有病率 n=593 Population-based estimates of post-acute sequelae of SARS-CoV-2 infection (PAS…
RT @kenmomd: COVID-19発症後30日以上、60日以上の持続的な症状と定義した後遺症の有病率 n=593 Population-based estimates of post-acute sequelae of SARS-CoV-2 infection (PAS…
COVID-19発症後30日以上、60日以上の持続的な症状と定義した後遺症の有病率 n=593 Population-based estimates of post-acute sequelae of SARS-CoV-2 infection (PASC) prevalence and characteristics Jana L Hirschtick et al. Clinical Infectious Diseases, 19 May 2021 https://t.co/zt5BQFyJ33 https
RT @IDSAInfo: New in CID: In a population-based probability sample of 593 symptomatic COVID-19 cases, 52.5% had persistent symptoms 30 days…
😭
RT @IDSAInfo: New in CID: In a population-based probability sample of 593 symptomatic COVID-19 cases, 52.5% had persistent symptoms 30 days…
RT @ahandvanish: Wow - new prevalence study looking specifically at symptomatic COVID patients finds 35% still symptomatic at 2 months. T…
RT @ontapphysio2: So much for “only 10%,” as some clinicians state. Are we as PTs and ATs prepared to help people with persistent multi-sys…
RT @ontapphysio2: So much for “only 10%,” as some clinicians state. Are we as PTs and ATs prepared to help people with persistent multi-sys…
RT @ItsAngInLA: So estimates of 1/3 of COVID patients will get #LongCovid seem to be right on target…
RT @ahandvanish: Wow - new prevalence study looking specifically at symptomatic COVID patients finds 35% still symptomatic at 2 months. T…
RT @IDSAInfo: New in CID: In a population-based probability sample of 593 symptomatic COVID-19 cases, 52.5% had persistent symptoms 30 days…
RT @ahandvanish: Wow - new prevalence study looking specifically at symptomatic COVID patients finds 35% still symptomatic at 2 months. T…
RT @ahandvanish: Wow - new prevalence study looking specifically at symptomatic COVID patients finds 35% still symptomatic at 2 months. T…
RT @IDSAInfo: New in CID: In a population-based probability sample of 593 symptomatic COVID-19 cases, 52.5% had persistent symptoms 30 days…
RT @IDSAInfo: New in CID: In a population-based probability sample of 593 symptomatic COVID-19 cases, 52.5% had persistent symptoms 30 days…
RT @IDSAInfo: New in CID: In a population-based probability sample of 593 symptomatic COVID-19 cases, 52.5% had persistent symptoms 30 days…
RT @ahandvanish: Wow - new prevalence study looking specifically at symptomatic COVID patients finds 35% still symptomatic at 2 months. T…
RT @IDSAInfo: New in CID: In a population-based probability sample of 593 symptomatic COVID-19 cases, 52.5% had persistent symptoms 30 days…
RT @ahandvanish: Wow - new prevalence study looking specifically at symptomatic COVID patients finds 35% still symptomatic at 2 months. T…
RT @IDSAInfo: New in CID: In a population-based probability sample of 593 symptomatic COVID-19 cases, 52.5% had persistent symptoms 30 days…
RT @IDSAInfo: New in CID: In a population-based probability sample of 593 symptomatic COVID-19 cases, 52.5% had persistent symptoms 30 days…
RT @IDSAInfo: New in CID: In a population-based probability sample of 593 symptomatic COVID-19 cases, 52.5% had persistent symptoms 30 days…
RT @ahandvanish: Wow - new prevalence study looking specifically at symptomatic COVID patients finds 35% still symptomatic at 2 months. T…
RT @ahandvanish: Wow - new prevalence study looking specifically at symptomatic COVID patients finds 35% still symptomatic at 2 months. T…
RT @IDSAInfo: New in CID: In a population-based probability sample of 593 symptomatic COVID-19 cases, 52.5% had persistent symptoms 30 days…
RT @IDSAInfo: New in CID: In a population-based probability sample of 593 symptomatic COVID-19 cases, 52.5% had persistent symptoms 30 days…
RT @IDSAInfo: New in CID: In a population-based probability sample of 593 symptomatic COVID-19 cases, 52.5% had persistent symptoms 30 days…
RT @IDSAInfo: New in CID: In a population-based probability sample of 593 symptomatic COVID-19 cases, 52.5% had persistent symptoms 30 days…
RT @ahandvanish: Wow - new prevalence study looking specifically at symptomatic COVID patients finds 35% still symptomatic at 2 months. T…
RT @ahandvanish: Wow - new prevalence study looking specifically at symptomatic COVID patients finds 35% still symptomatic at 2 months. T…
RT @ahandvanish: Wow - new prevalence study looking specifically at symptomatic COVID patients finds 35% still symptomatic at 2 months. T…
RT @ahandvanish: Wow - new prevalence study looking specifically at symptomatic COVID patients finds 35% still symptomatic at 2 months. T…
RT @ahandvanish: Wow - new prevalence study looking specifically at symptomatic COVID patients finds 35% still symptomatic at 2 months. T…
RT @ahandvanish: Wow - new prevalence study looking specifically at symptomatic COVID patients finds 35% still symptomatic at 2 months. T…
RT @ahandvanish: Wow - new prevalence study looking specifically at symptomatic COVID patients finds 35% still symptomatic at 2 months. T…
RT @ahandvanish: Wow - new prevalence study looking specifically at symptomatic COVID patients finds 35% still symptomatic at 2 months. T…
RT @ahandvanish: Wow - new prevalence study looking specifically at symptomatic COVID patients finds 35% still symptomatic at 2 months. T…
RT @ahandvanish: Wow - new prevalence study looking specifically at symptomatic COVID patients finds 35% still symptomatic at 2 months. T…
RT @IDSAInfo: New in CID: In a population-based probability sample of 593 symptomatic COVID-19 cases, 52.5% had persistent symptoms 30 days…
RT @ahandvanish: Wow - new prevalence study looking specifically at symptomatic COVID patients finds 35% still symptomatic at 2 months. T…
RT @IDSAInfo: New in CID: In a population-based probability sample of 593 symptomatic COVID-19 cases, 52.5% had persistent symptoms 30 days…
RT @IDSAInfo: New in CID: In a population-based probability sample of 593 symptomatic COVID-19 cases, 52.5% had persistent symptoms 30 days…
RT @ahandvanish: Wow - new prevalence study looking specifically at symptomatic COVID patients finds 35% still symptomatic at 2 months. T…
RT @ahandvanish: Wow - new prevalence study looking specifically at symptomatic COVID patients finds 35% still symptomatic at 2 months. T…
RT @ahandvanish: Wow - new prevalence study looking specifically at symptomatic COVID patients finds 35% still symptomatic at 2 months. T…
RT @ahandvanish: Wow - new prevalence study looking specifically at symptomatic COVID patients finds 35% still symptomatic at 2 months. T…
RT @ahandvanish: Wow - new prevalence study looking specifically at symptomatic COVID patients finds 35% still symptomatic at 2 months. T…
RT @ahandvanish: Wow - new prevalence study looking specifically at symptomatic COVID patients finds 35% still symptomatic at 2 months. T…